ANI Pharma (ANIP) Tops Q2 EPS by 1c

ANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $0.55, $0.01 better than the analyst estimate of $0.54. Revenue for the quarter came in at $19.52 million versus the consensus estimate of $20.3 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Ribbon Communications (RBBN) Misses Q1 EPS by 2c; offers guidance
• Magyar Bancorp (MGYR) Reports Q2 EPS of $0.30